Early use of a phosphodiesterase inhibitor after brachytherapy restores and preserves erectile function

Jonathan D. Schiff , Natan Bar-Chama , Jaime Cesaretti , Richard Stock
BJUI 98 ( 6) 1255 -1258

44
2006
Prostate-specific antigen bounce after prostate seed implantation for localized prostate cancer: descriptions and implications.

Richard G Stock , Nelson N Stone , Jamie A Cesaretti
International Journal of Radiation Oncology Biology Physics 56 ( 2) 448 -453

119
2003
Urinary symptom flare following I-125 prostate brachytherapy.

Jamie A Cesaretti , Nelson N Stone , Richard G Stock
International Journal of Radiation Oncology Biology Physics 56 ( 4) 1085 -1092

62
2003
Combined modality treatment in the management of high-risk prostate cancer.

Richard G Stock , Oren Cahlon , Jamie A Cesaretti , Marisa A Kollmeier
International Journal of Radiation Oncology Biology Physics 59 ( 5) 1352 -1359

134
2004
Individual patient data meta-analysis shows a significant association between the ATM rs1801516 SNP and toxicity after radiotherapy in 5456 breast and prostate cancer patients.

Christian Nicolaj Andreassen , Barry S Rosenstein , Sarah L Kerns , Harry Ostrer
Radiotherapy and Oncology 121 ( 3) 431 -439

57
2016
52
2007
Biologically effective dose values for prostate brachytherapy: effects on PSA failure and posttreatment biopsy results

Richard G Stock , Nelson N Stone , Jamie A Cesaretti , Barry S Rosenstein
International Journal of Radiation Oncology* Biology* Physics 64 ( 2) 527 -533

268
2006
ATM sequence variants are predictive of adverse radiotherapy response among patients treated for prostate cancer

Jamie A Cesaretti , Richard G Stock , Steven Lehrer , David A Atencio
International Journal of Radiation Oncology* Biology* Physics 61 ( 1) 196 -202

99
2005
Assessment of postbrachytherapy sexual function: a comparison of the IIEF-5 and the MSEFS

Timothy M Zagar , Richard G Stock , Jamie A Cesaretti , Nelson N Stone
Brachytherapy 6 ( 1) 26 -33

29
2007
SE Form Approved

Jamie A Cesaretti

2005
Proton Therapy for Prostate Cancer

Jamie A Cesaretti , Mitchell D Terk

Genetic Predictors of Adverse Radiotherapy Effects: The Gene-PARE project

Alice Y Ho , David P Atencio , Sheila Peters , Richard G Stock
International Journal of Radiation Oncology*Biology*Physics 65 ( 3) 646 -655

158
2006
ATM sequence variants and risk of radiation-induced subcutaneous fibrosis after postmastectomy radiotherapy.

Christian N Andreassen , Jens Overgaard , Jan Alsner , Marie Overgaard
International Journal of Radiation Oncology Biology Physics 64 ( 3) 776 -783

82
2006
Late exacerbation of urinary symptoms following I-125 prostate brachytherapy

J.A Cesaretti , N.N Stone , R.G Stock
International Journal of Radiation Oncology Biology Physics 54 ( 2) 45

1
2002
Role of external beam radiation and hormonal therapy in low, intermediate, and high risk patients treated with permanent radioactive seed implantation

A.M Dosoretz , R.G Stock , J.A Cesaretti , N.N Stone
International Journal of Radiation Oncology*Biology*Physics 57 ( 2) S227

2
2003
URINARY MORBIDITY AND INCONTINENCE FOLLOWING TRANSURETHRAL RESECTION OF THE PROSTATE AFTER BRACHYTHERAPY

M.A. KOLLMEIER , R.G. STOCK , J. CESARETTI , N.N. STONE
The Journal of Urology 173 ( 3) 808 -812

83
2005
ATM sequence variants are predictive of adverse radiotherapy response among patients treated for prostate cancer.

JA Cesaretti , RG Stock , DA Atencio , JL Bernstein
International Journal of Radiation Oncology Biology Physics 61 ( 1) 196 -202

80
2004
ATM sequence variants as predictors for adverse radiation responses in breast cancer patients.

AY Ho , DP Atencio , G Fan , S Green
BREAST CANCER RESEARCH AND TREATMENT 94 S178 -S178

2005